Anxiety, Depression, and Apathy as Predictors of Cognitive Decline in Patients With Parkinson's Disease—A Three-Year Follow-Up Study

Anxiety, Depression, and Apathy as Predictors of Cognitive Decline in Patients With Parkinson's Disease—A Three-Year Follow-Up Study

ObjectiveAnxiety, depression, and apathy are the most common neuropsychiatric symptoms in Parkinson's disease (PD) patients. They impair cognitive functioning and have a profound impact on quality of life. This follow-up study aims to investigate the predictive value of anxiety, depression, and...

Full description

Bibliographic Details
Main Authors:	Ketevan Toloraia, Antonia Meyer, Selina Beltrani, Peter Fuhr, Roselind Lieb, Ute Gschwandtner
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-02-01
Series:	Frontiers in Neurology
Subjects:	anxiety mild cognitive impairment Parkinson's disease neuropsychology neuropsychiatry
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.792830/full

Similar Items

Apathy in Patients with Parkinson's Disease Correlates with Alteration of Left Fronto-Polar Electroencephalographic Connectivity
by: Florian Hatz, et al.
Published: (2017-08-01)

Influence of Mild Cognitive Impairment, Depression, and Anxiety on the Quality of Life of Patients with Parkinson Disease
by: Daniel Wiesli, et al.
Published: (2017-09-01)

Neuropsychiatric symptoms and faster progression of cognitive impairments as predictors of risk of conversion of mild cognitive impairment to dementia
by: Mariola Bidzan, et al.
Published: (2017-07-01)

High-frequency multimodal training with a focus on Tai Chi in people with Parkinson’s disease: a pilot study
by: Ketevan Toloraia, et al.
Published: (2024-02-01)

Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype
by: Ségolène De Waele, et al.
Published: (2022-07-01)

Slowing of EEG background activity in Parkinson´s and Alzheimer´s Disease with early cognitive dysfunction
by: Nina eBenz, et al.
Published: (2014-11-01)

Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease
by: Dana Pourzinal, et al.
Published: (2023-10-01)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
by: Alessandra Nicoletti, et al.
Published: (2019-02-01)

Pituitary adenoma with hypothalamic involvement: a case of ‘atypical’ atypical depression
by: Manjunadh Muraleedharan, et al.
Published: (2018-07-01)

Predictors of Mild Cognitive Impairment in Early-Stage Parkinson's Disease
by: Brenda Hanna-Pladdy, et al.
Published: (2013-05-01)

Neuropsychological and Neuropsychiatric Features of Chronic Migraine Patients during the Interictal Phase
by: Elena Lozano-Soto, et al.
Published: (2023-01-01)

Predictors of cognitive impairment in newly diagnosed Parkinson’s disease with normal cognition at baseline: A 5-year cohort study
by: Jing Chen, et al.
Published: (2023-02-01)

Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson’s disease patients with mild cognitive impairment
by: Alberto eCosta, et al.
Published: (2015-09-01)

Language, memory, and cognition in infancy and early childhood /
by: Benson, Janette B., et al.
Published: (2009)

Apathy in Parkinson`s disease is related to executive function, gender and age but not to depression
by: Antonia eMeyer, et al.
Published: (2015-01-01)

Evaluation of Available Cognitive Tools Used to Measure Mild Cognitive Decline: A Scoping Review
by: Chian Thong Chun, et al.
Published: (2021-11-01)

Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease
by: Alfonso Delgado-Álvarez, et al.
Published: (2023-01-01)

Depression, Anxiety, and Apathy in Mild Cognitive Impairment: Current Perspectives
by: Lina Ma
Published: (2020-01-01)

Child Neuropsychology [electronic resource]: Assessment and Interventions for Neurodevelopmental Disorders/
by: 228844 Ellison, Phyllis Anne Teeter, et al.
Published: (2007)

Child Neuropsychology [electronic resource]: Assessment and Interventions for Neurodevelopmental Disorders/
by: 228844 Ellison, Phyllis Anne Teeter, et al.
Published: (2007)

Cortical functions /
by: Stirling, John D., 1951-
Published: (2000)

Apathy - where do we find it and how to treat
by: R. Gomes, et al.
Published: (2022-06-01)

Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
by: Alfonso Delgado-Álvarez, et al.
Published: (2023-05-01)

Subjective cognitive decline in patients with Parkinson’s disease: an updated review
by: Juan Huang, et al.
Published: (2023-05-01)

Differential impact of resilience on demoralization and depression in Parkinson disease
by: John M. de Figueiredo, et al.
Published: (2023-07-01)

Structural and Functional Changes in Mild Cognitive Impairment in Parkinson’s Disease
by: Halil Güllüoğlu, et al.
Published: (2023-12-01)

Apathy and APOE in mild behavioral impairment, and risk for incident dementia
by: Daniella Vellone, et al.
Published: (2022-01-01)

Making up the mind : how the brain creates our mental world /
by: 203801 Frith, Christopher D.
Published: (2007)

Current level of knowledge about Parkinson’s disease cognitive impairment
by: Lilia Rotaru, et al.
Published: (2023-12-01)

Brief Tests such as the Clock Drawing Test or Cognistat Can Be Useful Predictors of Conversion from MCI to Dementia in the Clinical Assessment of Outpatients
by: Magnar Nesset, et al.
Published: (2014-07-01)

Cognitive impairment and dementia in Parkinson's disease
by: Javier Pagonabarraga, et al.
Published: (2012-06-01)

Mild Behavioral Impairment in Parkinson’s Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects
by: Efthalia Angelopoulou, et al.
Published: (2024-01-01)

Effects of Cognitive Performance and Affective Status on Fatigue in Parkinson’s Disease
by: Susan Spirgi, et al.
Published: (2019-09-01)

Management of Parkinson’s disease challenged by co-morbid drug abuse
by: J. Simas, et al.
Published: (2022-06-01)

Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson’s Disease Dementia
by: Yoon-Sang Oh, et al.
Published: (2015-05-01)

Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson’s and Huntington’s disease
by: Barbara Poletti, et al.
Published: (2022-11-01)

Increase of EEG spectral theta power indicates higher risk of the development of severe cognitive decline in Parkinson’s disease after 3 years
by: Vitalii V Cozac, et al.
Published: (2016-11-01)

When is diminishment a form of enhancement? Rethinking the enhancement debate in biomedical ethics
by: Brian D. Earp, et al.
Published: (2014-02-01)

Treatment of Parkinson’s Disease with Cognitive Impairment: Current Approaches and Future Directions
by: Chichun Sun, et al.
Published: (2021-04-01)

“Smelling and Tasting” Parkinson's Disease: Using Senses to Improve the Knowledge of the Disease
by: Valentina Oppo, et al.
Published: (2020-02-01)